SEARCH

SEARCH BY CITATION

References

  • 1
    Matsumoto K & Nakamura T (2006) Hepatocyte growth factor and the Met system as a mediator of tumor–stromal interactions. Int J Cancer 119, 477483.
  • 2
    Kataoka H, Miyata S, Uchinokura S & Itoh H (2003) Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor. Cancer Metastasis Rev 22, 223236.
  • 3
    Szabo R & Bugge TH (2008) Type II transmembrane serine proteases in development and disease. Int J Biochem Cell Biol 40, 12971316.
  • 4
    Shimomura T, Ochiai M, Kondo J & Morimoto Y (1992) A novel protease obtained from FBS-containing culture supernatant, that processes single chain form hepatocyte growth factor to two chain form in serum-free culture. Cytotechnology 8, 219229.
  • 5
    Miyazawa K, Shimomura T, Kitamura A, Kondo J, Morimoto Y & Kitamura N (1993) Molecular cloning and sequence analysis of the cDNA for a human serine protease reponsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII. J Biol Chem 268, 1002410028.
  • 6
    Kitajima Y, Ide T, Ohtsuka T & Miyazaki K (2008) Induction of hepatocyte growth factor activator gene expression under hypoxia activates the hepatocyte growth factor/c-Met system via hypoxia inducible factor-1 in pancreatic cancer. Cancer Sci 99, 13411347.
  • 7
    Itoh H, Hamasuna R, Kataoka H, Yamauchi M, Miyazawa K, Kitamura N & Koono M (2000) Mouse hepatocyte growth factor activator gene: its expression not only in the liver but also in the gastrointestinal tract. Biochim Biophys Acta 1491, 295302.
  • 8
    Kataoka H, Shimomura T, Kawaguchi T, Hamasuna R, Itoh H, Kitamura N, Miyazawa K & Koono M (2000) Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment. J Biol Chem 275, 4045340462.
  • 9
    Eigenbrot C, Ganesan R & Kirchhofer D (2010) Hepatocyte growth factor activator (HGFA): molecular structure and interactions with HAI-1. FEBS J 277, 22152222.
  • 10
    Suzuki K (2010) Hepatocyte growth factor activator (HGFA): its regulation by protein C inhibitor. FEBS J 277, 22232229.
  • 11
    Shimomura T, Kondo J, Ochiai M, Naka D, Miyazawa K, Morimoto Y & Kitamura N (1993) Activation of the zymogen of hepatocyte growth factor activator by thrombin. J Biol Chem 268, 2292722932.
  • 12
    Nagakawa O, Yamagishi T, Fujiuchi Y, Junicho A, Akashi T, Nagaike K & Fuse H (2005) Serum hepatocyte growth factor activator (HGFA) in benign prostatic hyperplasia and prostate cancer. Eur Urol 48, 686690.
  • 13
    Wader KF, Fagerli UM, Holt RU, Stordal B, Borset M, Sundan A & Waage A (2008) Elevated serum concentrations of activated hepatocyte growth factor activator in patients with multiple myeloma. Eur J Haematol 81, 380383.
  • 14
    van Adelsberg J, Sehgal S, Kukes A, Brady C, Barasch J, Yang J & Huan Y (2001) Activation of hepatocyte growth factor (HGF) by endogenous HGF activator is required for metanephric kidney morphogenesis in vitro. J Biol Chem 276, 1509915106.
  • 15
    Hayashi T, Abe K, Sakurai M & Itoyama Y (1998) Induction of hepatocyte growth factor and its activator in rat brain with permanent middle cerebral artery occlusion. Brain Res 799, 311316.
  • 16
    Nagashima M, Hasegawa J, Kato K, Yamazaki J, Nishigai K, Ishiwata T, Asano G & Yoshino S (2001) Hepatocyte growth factor (HGF), HGF activator, and c-Met in synovial tissues in rheumatoid arthritis and osteoarthritis. J Rheumatol 28, 17721778.
  • 17
    Lee YR, Yamazaki M, Mitsui S, Tsuboi R & Ogawa H (2001) Hepatocyte growth factor (HGF) activator expressed in hair follicles is involved in in vitro HGF-dependent hair follicle elongation. J Dermatol Sci 25, 156163.
  • 18
    Moriyama T, Kataoka H, Tsubouchi H & Koono M (1995) Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-met genes in human glioma cells in vitro. FEBS Lett 372, 7882.
  • 19
    Kataoka H, Hamasuna R, Itoh H, Kitamura N & Koono M (2000) Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma. Cancer Res 60, 61486159.
  • 20
    Tjin EP, Derksen PW, Kataoka H, Spaargaren M & Pals ST (2004) Multiple myeloma cells catalyze hepatocyte growth factor (HGF) activation by secreting the serine protease HGF-activator. Blood 104, 21722175.
  • 21
    Tjin EP, Groen RW, Vogelzang I, Derksen PW, Klok MD, Meijer HP, van Eeden S, Pals ST & Spaargaren M (2006) Functional analysis of HGF/MET signaling and aberrant HGF-activator expression in diffuse large B-cell lymphoma. Blood 107, 760768.
  • 22
    Su W, Gutmann DH, Perry A, Abounader R, Laterra J & Sherman LS (2004) CD44-independent hepatocyte growth factor/c-Met autocrine loop promotes malignant peripheral nerve sheath tumor cell invasion in vitro. Glia 45, 297306.
  • 23
    Parr C & Jiang WG (2001) Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells. Int J Oncol 19, 857863.
  • 24
    Miyazawa K, Shimomura T & Kitamura N (1996) Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator. J Biol Chem 271, 36153618.
  • 25
    Mukai S, Fukushima T, Naka D, Tanaka H, Osada Y & Kataoka H (2008) Activation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidases. FEBS J 275, 10031017.
  • 26
    Kawaguchi M, Orikawa H, Baba T, Fukushima T & Kataoka H (2009) Hepatocyte growth factor activator is a serum activator of single-chain precursor macrophage-stimulating protein. FEBS J 276, 34813490.
  • 27
    Wang MH, Zhou YQ & Chen YQ (2002) Macrophage-stimulating protein and RON receptor tyrosine kinase: potential regulators of macrophage inflammatory activities. Scand J Immunol 56, 545553.
  • 28
    Matsubara Y, Ichinose M, Yahagi N, Tsukada S, Oka M, Miki K, Kimura S, Omata M, Shiokawa K, Kitamura N et al. (1998) Hepatocyte growth factor activator: a possible regulator of morphogenesis during fetal development of the rat gastrointestinal tract. Biochem Biophys Res Commun 253, 477484.
  • 29
    Tjin EP, Bende RJ, Derksen PW, van Huijstee AP, Kataoka H, Spaargaren M & Pals ST (2005) Follicular dendritic cells catalyze hepatocyte growth factor (HGF) activation in the germinal center microenvironment by secreting the serine protease HGF activator. J Immunol 175, 28072813.
  • 30
    Itoh H, Naganuma S, Takeda N, Miyata S, Uchinokura S, Fukushima T, Uchiyama S, Tanaka H, Nagaike K, Shimomura T et al. (2004) Regeneration of injured intestinal mucosa is impaired in hepatocyte growth factor activator-deficient mice. Gastroenterology 127, 14231435.
  • 31
    Miyazawa K (2010) Hepatocyte growth factor activator (HGFA): a serine protease that links tissue injury to activation of hepatocyte growth factor. FEBS J 277, 22082214.
  • 32
    Tang W, Miyazawa K & Kitamura N (1995) Hepatocyte growth factor remains as an inactive single chain after partial hepatectomy or unilateral nephrectomy. FEBS Lett 362, 220224.
  • 33
    Kaibori M, Inoue T, Oda M, Naka D, Kawaguchi T, Kitamura N, Miyazawa K, Kwon AH, Kamiyama Y & Okumura T (2002) Exogenously administered HGF activator augments liver regeneration through the production of biologically active HGF. Biochem Biophys Res Commun 290, 475481.
  • 34
    Nagai M, Takahashi N, Miyazawa K, Kawaguchi M, Chijiiwa K & Kataoka H (2008) Activation of MET receptor tyrosine kinase in ulcer surface epithelial cells undergoing restitution. Pathol Int 58, 462464.
  • 35
    Marchand-Adam S, Fabre A, Mailleux AA, Marchal J, Quesnel C, Kataoka H, Aubier M, Dehoux M, Soler P & Crestani B (2006) Defect of pro-hepatocyte growth factor activation by fibroblasts in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 174, 5866.
  • 36
    Phin S, Marchand-Adam S, Fabre A, Marchal-Somme J, Bantsimba-Malanda C, Kataoka H, Soler P & Crestani B (2010) Imbalance in the pro-HGF activation system in bleomycin-induced lung fibrosis in mice. Am J Respir Cell Mol Biol, 42, 288293.
  • 37
    Olivero M, Rizzo M, Madeddu R, Casadio C, Pennacchietti S, Nicotra MR, Prat M, Maggi G, Arena N, Natali PG et al. (1996) Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas. Br J Cancer 74, 18621868.
  • 38
    Uchinokura S, Miyata S, Fukushima T, Itoh H, Nakano S, Wakisaka S & Kataoka H (2006) Role of hepatocyte growth factor activator (HGF activator) in invasive growth of human glioblastoma cells in vivo. Int J Cancer 118, 583592.
  • 39
    Parr C & Jiang WG (2006) Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells. Int J Cancer 119, 11761183.
  • 40
    Morris MR, Gentle D, Abdulrahman M, Maina EN, Gupta K, Banks RE, Wiesener MS, Kishida T, Yao M, Teh B et al. (2005) Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma. Cancer Res 65, 45984606.
  • 41
    Nakamura K, Abarzua F, Hongo A, Kodama J, Nasu Y, Kumon H & Hiramatsu Y (2009) Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer. Ann Oncol 20, 6370.
  • 42
    Hamasuna R, Kataoka H, Meng JY, Itoh H, Moriyama T, Wakisaka S & Koono M (2001) Reduced expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin (HAI-2/PB) in human glioblastomas: implication for anti-invasive role of HAI-2/PB in glioblastoma cells. Int J Cancer 93, 339345.
  • 43
    Kongkham PN, Northcott PA, Ra YS, Nakahara Y, Mainprize TG, Croul SE, Smith CA, Taylor MD & Rutka JT (2008) An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma. Cancer Res 68, 99459953.
  • 44
    Fukai K, Yokosuka O, Chiba T, Hirasawa Y, Tada M, Imazeki F, Kataoka H & Saisho H (2003) Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma. Cancer Res 63, 86748679.
  • 45
    Yasuda K, Nagakawa O, Akashi T, Fujiuchi Y, Koizumi K, Komiya A, Saiki I & Fuse H (2009) Serum active hepatocyte growth factor (AHGF) in benign prostatic disease and prostate cancer. Prostate 69, 346351.
  • 46
    Parr C, Watkins G, Mansel RE & Jiang WG (2004) The hepatocyte growth factor regulatory factors in human breast cancer. Clin Cancer Res 10, 202211.